Pilot Therapeutics Holdings, Inc. (PLTT)

[MWM]

Nutrition-based therapies to prevent and treat targeted, chronic inflammatory conditions in companion animals

Similar dynamics contributing to chronic inflammatory diseases in humans can be seen in our pets.

It is estimated that 40% of dogs in America are overweight or obese. With a trend towards humanization of pets, owners are increasingly interested in nutrition-based therapies for their pets that are proven effective, safe, and without side effects.

Based on our discoveries utilizing our Gene Smart Nutrigenomics Discovery platform, we are developing a pipeline of products to address the growing need worldwide for safe, gentle, and potent therapies to manage targeted chronic inflammatory diseases in companion animals with products containing combinations of natural bioactives.